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  A b s t r a c t
    Cerebral small vessel disease, a leading cause of cognitive decline, is considered a relatively 
homogeneous disease process, and it can co-occur with Alzheimer’s disease. Clinical reports 
of magnetic resonance imaging (MRI)/computed tomography and single photon emission 
computed tomography (SPECT) imaging and neuropsychology testing for a small pilot sample 
of 14 patients are presented to illustrate disease characteristics through findings from struc-
tural and functional imaging and cognitive assessment. Participants showed some decreases 
in executive functioning, attention, processing speed, and memory retrieval, consistent with 
previous literature. An older subgroup showed lower age-corrected scores at a single time 
point compared to younger participants. Performance on a computer-administered cognitive 
measure showed a slight overall decline over a period of 8–28 months. For a case study with 
mild neuropsychology findings, the MRI report was normal while the SPECT report identified 
perfusion abnormalities. Future research can test whether advances in imaging analysis allow 
for identification of cerebral small vessel disease before changes are detected in cognition. 
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  Introduction
  As our life span lengthens, and as the proportion of older adults in our population grows, 
cognitive changes from cerebrovascular disease are becoming an increasingly common 
problem. With disease progression these changes can result in dementia, with decreased 
quality of life and a substantial burden of care for family members and the larger commu-
nity.
    While Alzheimer’s disease is the most common cause of dementia, cerebrovascular dis-
ease has been considered the second most common etiology of dementia in the US   [1]  . Cere-
bral small vessel disease, as distinct from large vessel disease and other forms of cerebrovas-
cular disease, is considered the most common etiology of vascular dementia. As noted in 
Pantoni [2], ‘The term cerebral small vessel disease refers to a group of pathological process-
es with various aetiologies that affect the small arteries, arterioles, venules, and capillaries of 
the brain. … Because lacunar infarcts and white matter lesions are easily detected by neuro-
imaging, whereas small vessels are not, the term small vessel disease is frequently used to 
describe the parenchyma lesions rather than the underlying small vessel alterations’.
    It is estimated that older adults with small vessel disease develop vascular dementia be-
tween 5 and 25 times more often than age-matched general population samples   [1]  . In clini-
cal studies, estimates of the proportion of dementia caused by small vessel disease range from 
36 to 67%   [3]  . In one study, mild cognitive impairment (MCI) preceded subcortical small 
vessel dementia in a substantial proportion of individuals   [4]  .
    The clinical diagnostic work-up of cognitive impairment from cerebrovascular disease 
and other etiologies generally includes neuropsychology testing to identify patterns of im-
pairment and often neuroimaging to aid in determining disease processes. Cognitive chang-
es from cerebral small vessel disease generally include decreases in attention and working 
memory, processing speed, executive functioning, and aspects of memory performance i.e., 
primarily retrieval and encoding rather than retention   [5–9]  . Zhou and Jia   [10]   found that 
patients with MCI from small vessel disease performed worse on processing speed and bet-
ter on memory than those with MCI from Alzheimer’s disease. Of course, cerebrovascular 
disease can occur with Alzheimer’s disease in so-called ‘mixed’ dementia.
    Brief, repeatable neuropsychological measures, such as the Repeatable Battery for As-
sessment of Neuropsychological Status (RBANS), have been developed that are well suited to 
assess and monitor cognition among older adults. Age- and education-adjusted normative 
data for the RBANS are available for community-dwelling individuals between 65 and 89 
  [11]  , and regression-based formulas for predicting change in scores have been developed for 
this same age group   [12]  .
    Computer-administered, very brief, repeatable assessments of cognitive performance, 
such as the CogHealth program, may also assist with identifying MCI and monitoring its 
progression with minimal practice effects. Darby et al.   [13]   found a sensitivity of 80% and a 
specificity of 95% for CogHealth in differentiating normal from MCI participants with mul-
tiple administrations at a single time point. Normal control and MCI groups were also dif-
ferent on change in memory performance from baseline to a 12-month follow-up. Four scales 
of the CogHealth battery measuring attention functions, processing speed, working memo-
ry, and continuous visual recognition learning correlated with six traditional neuropsycho-
logical measures (Spatial Span, Symbol Digit Modalities, Grooved Pegboard, Trail Making 
Test, Brief Visual Memory Test Total Immediate Recall, and Rey Complex Figure 30 Minute 
Recall) to a degree that provided support for the construct validity of specific scales of the 
computer measure   [14]  .
    Both structural neuroimaging, including magnetic resonance imaging (MRI) and com-
puted tomography (CT), and functional neuroimaging, including single photon emission 171
Dement Geriatr Cogn Disord Extra 2012;2:169–179
 DOI:  10.1159/000333482 
  Published online: April 18, 2012 
EXTRA
  Baker et al.: Cerebral Small Vessel Disease 
www.karger.com/dee
  © 2012 S. Karger AG, Basel 
computed tomography (SPECT) and positron emission tomography (PET), have been used 
to determine disease processes related to cognitive decline. Sabri et al.   [15]   compared evi-
dence of cerebral small vessel disease from PET, SPECT, and MRI to cognitive impairment. 
They found that neuropsychological deficits correlated well with decreased glucose metabo-
lism on PET and decreased regional cerebral blood flow on SPECT. Lacunar infarctions and 
deep white matter hyperintensities seen on MRI did not correlate with neuropsychological 
deficits nor PET metabolism and SPECT blood flow. They concluded that lacunar infarctions 
and deep white matter hyperintensities seen on MRI may be epiphenomena that morpho-
logically characterize cerebral small vessel disease, but do not in and of themselves indicate 
cognitive impairment. Yoshikawa et al.   [16]   suggested that three-dimensional assessment of 
cerebral blood flow with SPECT may be able to detect incipient dementia in clinical settings 
before morphologic changes are seen on MRI or CT.
    Nonetheless, a more recent study found that periventricular white matter lesions, lacu-
nar infarcts, and atrophy on MRI were specifically associated with decline in information 
processing speed and executive function   [9]  . Grau-Olivares et al.   [17]   compared neuropsy-
chology test scores across five subtypes of first-ever acute lacunar infarction on MRI and 
found that mild neuropsychological disturbances occurred in more than half the cases, with 
55% fulfilling the criteria for MCI of vascular origin. In a recent review of the literature on 
MCI in patients with small vessel disease, Grau-Olivares and Arboix   [5]   note that neuropsy-
chological abnormalities from small vessel disease occur more frequently than believed pre-
viously, and that patients with subcortical vascular dementia represent a highly prevalent 
and homogeneous group.
    Authors have noted that subcortical ischemic vascular dementia from small vessel dis-
ease has been underrecognized in clinical settings and understudied in the research litera-
ture  [5, 17] . In this pilot study, we present some preliminary cognitive, mood, daily function-
ing, and imaging data from a small pilot sample of patients with cerebral small vessel disease. 
Age-corrected cross-sectional test scores are compared between older and younger groups, 
and we present multiple computerized test scores over a 1- to 3-year period. We include a 
case study to illustrate the relation between neuropsychological test results and findings 
from clinical reports of structural and functional imaging. We hypothesized that we would 
find decreases in neuropsychological measures characteristic of cerebral small vessel disease 
(i.e. attention, speed, executive function, and memory retrieval) with greater decreases 
among older participants. We also expected to find heterogeneous regions of hypoperfusion 
in SPECT reports for individual participants in the pilot sample.
  M e t h o d s
  P a r t i c i p a n t s
    Patients seen for follow-up at a stroke center clinic were screened according to specific 
inclusion and exclusion criteria as specified on a checklist used by the neurologists and re-
search nurses who recruited patients for this study. Patients were eligible if they were   1  45 
years, had a diagnosis of hypertension or diabetes, and at least one other vascular risk factor. 
    To be included patients also needed to be determined to be at risk for subcortical vascu-
lar cognitive impairment [as specified in   18–20  ]. Examples included a history of subcortical 
stroke; dizziness due to hypoperfusion; gait disturbance or other motor dysfunction (e.g. 
subtle focal signs such as arm drift, unilateral incoordination, extrapyramidal features); re-
ported cognitive impairment such as dysexecutive syndrome or forgetfulness; or neuroimag-
ing findings such as white matter hyperintensities or lacunes.172
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  Exclusion criteria included significant known large vessel cerebrovascular disease; a his-
tory of large vessel stroke or large vessel transient ischemic attack; a current diagnosis of de-
mentia; use of cholinesterase inhibitors or other dementia medications; a pattern of symp-
toms consistent with Alzheimer’s disease or other neurodegenerative disease etiologies that 
could lead to MCI or dementia (e.g. Parkinson’s Disease, Multiple Sclerosis, Traumatic Brain 
Injury); or a life expectancy of less than a year.
    As noted above, with the exception of one participant, patients were recruited from a 
stroke center clinic, and generally had experienced a mild clinically evident lacunar stroke. 
The study was explained to eligible patients, and interested patients read and signed an in-
formed consent form. The study was approved by the University at Buffalo Health Sciences 
Institutional Review Board.
  P r o c e d u r e s
    Measures of Cognition, Mood, and Daily Functioning
  Study participants were administered an initial assessment that included traditional and 
computer-based measures, and follow-up assessments with only the computer-based assess-
ment and brief mood and daily functioning questionnaires. At initial assessment, partici-
pants completed a short battery of neuropsychological tasks including the RBANS, the Dig-
it Span subtest of the Wechsler Adult Intelligence Scale-Third Edition (WAIS), Trail Making 
Test – Parts A and B (TMT A, TMT B), Clock Drawing Tests (CLOX1, CLOX2), Controlled 
Oral Word Association Test (FAS), Animals Test of Semantic Verbal Fluency (Animals), Ge-
riatric Depression Scale (GDS), Medical Outcomes Study Short Form-36 (SF-36), and the 
CogHealth Memory Monitoring System (CogHealth). At the follow-up assessments, partici-
pants completed only the CogHealth, GDS, and SF-36.
  N e u r o i m a g i n g
  Participants received a SPECT imaging study at the time of their enrollment using Neu-
rolite. These imaging studies were read by a dual board certified neurologist and nuclear 
medicine physician and a clinical report was generated. Clinical reports from other imaging 
studies completed before and during the period of the study (i.e. existing MRI or CT images 
as part of stroke assessment or other regular clinical care) were included as part of the study.
  R e s u l t s
    Fourteen patients who met the inclusion and exclusion criteria enrolled in the study. 
  Table 1   presents demographics for this pilot sample. As indicated in   table 1  , participants are 
predominantly female and White, and many have some college education. There is a wide 
age range from 50 to 86 years. The sample was divided into an older and younger group based 
on the median age. 
      Table 2   presents mean standard scores for the cognitive, mood, and daily functioning 
measures for the older, younger, and combined age groups at the initial assessment. As can 
be seen in   table 2  , the age-referenced index scores from the RBANS manual and the age-
referenced subtests scores from Lezak et al.   [21]  , as well as the norm-referenced scores for 
other traditional neuropsychological tests are generally somewhat lower for the older group. 
These differences reached statistical significance for the RBANS story memory and coding 
subtests and for the GDS raw scores. Differences for the RBAN3 Immediate Memory Index 
score approached significance.
  While many of the mean scores for the younger group are close to the mean for their age 
groups (i.e. a standard score of 100 and a standard deviation of 15), many of the mean scores 173
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  Table  1.  D  emographic information
 Younger  participants
  (ages  50–71) 
 Older  participants
  (ages  72–86) 
 Entire  sample 
  Number of participants  7  7  14 
 Mean  age  8 SD, years    61.787.65 78.385.18 70.0810.65 
 Mean  education  8 SD, years    14.982.04 13.083.56   13.9382.95 
  Sex, % female    57.1  71.4  64.3 
 Ethnicity,  %  White   85.7   100.0  92.9 
 
 
  Table 2.  R  BANS index scores and subtest scores (age-corrected standard scores as defined by RBANS manual), TMT A and 
B standard scores, CLOX1 and 2 standard scores, FAS standard score, WAIS Digit Span subtest standard scores, SF-36   daily 
functioning scores, and GDS raw scores for baseline sample
 Measure   Younger  participants
  (ages  50–71)
  (n  =  7) 
 Older  participants
  (ages  72–86)
  (n  =  7) 
  Combined sample means 
and group difference effect 
sizes (ages 50–86) (n = 1  4) 
 mean  8 SD   range   mean  8 SD  range   mean  8 S  D  effect size 
  RBANS index and subtest scores 
 Immediate  memory   11088.4   94–120  91824.7a  53–117   101820.4  0.28 
 List  learning   110812.2   84–120  94825.6  57–123   102821.0  0.21 
 Story  memory   11187.6   98–118  88821.4b  57–103  99819.7  0.39 
 Visuospatial/constructional   111815.0   92–131   10786.6  96–116   109811.3  0.08 
 Figure  copy   105822.5   55–119   106812.7  83–118   105817.5   –0.01 
 Line  orientation   108811.2   88–119   10789.0  93–114   10889.8  0.04 
 Language   10089.2   88–113   10089.5  85–112   10089.0  0.08 
 Picture  naming   10288.7   91–109   101811.0  84–109   10189.6  0.04 
 Semantic  fluency   101814.8   80–121   103821.4  72–139   102817.7   –0.03 
 Attention   10288.4   88–115  94811.8  79–109  98810.8  0.22 
 Digit  span   104816.4   86–134   101816.1  82–128   102815.7  0.06 
 Coding   10187.0   92–110  87811.7c  68–105  94811.6  0.39 
 Delayed  memory   10189.9   81–112  94822.8  48–114  98817.3  0.11 
 List  recall   106813.5   93–129   104817.0  71–127   105814.8  0.03 
 List  recognition   10389.0   85–108  93822.1  48–113  98816.9  0.15 
 Story  recall   101812.7   84–119  95823.7  52–114  98818.5  0.07 
 Figure  recall  98810.2   84–117  89815.4  59–106  94813.5  0.20 
 Total  score   10689.2   89–117  96814.8  70–110   101813.1  0.23 
  TMT – Part Ae   10689.6   97–123  9689.3  87–109   101810.4  0.25 
  TMT – Part Bf  99821.1   60–118  9487.3  82–101  97815.9  0.08 
 CLOX1e    10987.4   95–117   103811.8  95–117   10689.6  0.13 
 CLOX2f   10487.9   97–112   10985.4   101–112   10687.2   –0.17 
 FASe  97811.0   86–112  91815.0  75–106  94812.7  0.12 
  WAIS Digit Span subtestg   10489.7   90–120  9487.5  85–100   100810.0  0.26 
 GDS  1387.0  4–21  6.484.5d  0–13  9.986.7  1.07 
 SF-36   
 Physical  composite  87816.8   56–106  87817.7  58–106  87816.6  0.01 
  Mental (emotional) composite  84816.9   55–100   100821.0  69–125  92820.2   –0.24 
 a p   = 0.087; b p = 0.027; c p = 0.021; d p = 0.046; e n = 11; f n = 10. 
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  Table  3.  C  omparison of CogHealth performance at baseline to follow-up
 M  easure   Baseline
  (n  =  9) 
  Follow-up (8 months–
    28 months) (n = 9) 
 Paired  difference
  and   effect  size 
 mean  8 SD   range   mean  8 SD   range   mean  8 SD  effect size   
 CogHealth 
  Detection 1: speed of processing   101.689.5   85–108  97.6816.6   67–108  4.089.1  0.15 
  Identification: visual identification task   101.186.1   88–107   100.088.5   80–107  1.1810.2  0.07 
  One back: working memory and













  One card learning: card-based 
    episodic memory and attention task 
 
  102.089.0 
 
  93–111 
 
  101.388.7 
 





  Monitoring: divided and spatial attention  98.088.1   84–106  96.787.0   85–105  1.389.2  0.09 
  Associate Learning: contextual memory 













  SF-36 (n = 8) 
  Physical composite (PCS)  85.2820.4   56–106  87.3816.8   60–106   –2.0815.0   –0.06 
  Mental (emotional) composite (MCS)  98.9817.2   69–125  99.4816.2   69–114   –0.587.7   –0.01 
 GDSa  8.186.8  0–18  6.685.4  0–16  1.684.1  0.12 
 a GDS   is a raw score where the score is equal to the number of depressive symptoms endorsed.
    Paired sample t tests did not show any statistically significant differences between baseline and follow-up scores.  
 
 
  Table  4.  C  linical report findings for structural and functional neuroimaging and neuropsychology test scores below one 
standard deviation for pilot sample
 Case   Age  group   MRI:  WMH/
lacunes/
  SVD  findings 
 SPECT:
    small vessel disease –
  hypoperfusion 
  Neuropsychological testing: domains below 1 SD from 
the normative mean  
1   older   yes/yes/no   mild  –  moderate   Attn,  Del  Memc 
2   older   yes/yes/yes   moderate   None c 
3   older   no/no/no   mild  –  moderate   Attn,  Speed c 
4    younger    no/yes/yes    mild – moderate    Del Mem, GDS, MCS 
5    older    yes/yes/yes    mild – moderate    Attn, Im and Del Mem, Lang, Ex Fx, GDS, MCS, PCS 
6    younger    no/no/yes    Attn, Im and Del Mem, Lang, Ex Fx, GDS, PCS 
7   younger   yes/no/no   mild  –  moderate   GDS,  MCS,  PCS 
8    younger    yes/no/no    mild – moderate    Wk Mem, Ex Fx 
9   older   yes/no/yes   moderate   Im  Mem,  PCS 
 10   younger   yes/no/yes   mild  –  moderate   GDS,  MCS,  PCS 
 11   younger   yes/no/no   mild  –  moderate   VS/Const 
 12   older   no/no/yesa    Attn, Wk Mem, Im and Del Mem, Lang, Ex Fx, MCS, 
PCS 
 13   younger   no/no/nob    incipient    Wk Mem, Ex Fx, MCS, PCS 
  14    older    no/no/yes    mild     Attn, Wk Mem, Im Mem, Lang, VS/Const, Ex Fx 
 a  Findings are consistent with cerebral amyloid angiopathy. b CT Scan. c Tests of executive functioning were not admin-
istered.
    WMH = white matter hyperintensities; SVD = small vessel disease; Attn = Attention; Wk Mem = working memory; Im 
Mem = immediate memory; Del Mem = delayed memory; Speed = processing speed; Lang = language; VS/Const = visual 
spatial/constructional; Ex Fx = executive functioning; PCS = SF-36 physical composite summary score; MCS = SF-36 men-
tal/emotional composite summary score. 175
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for the older group are somewhat below the mean score for their age group. The older group 
showed significantly less depression than the younger group as indicated by their raw scores 
on the GDS. Their scores on the SF-36 Mental Composite Scale (MCS), which are non-age-
referenced to the general US population, also showed better mood and emotional role func-
tioning compared to the younger group. Physical functioning (SF-36 Physical Composite 
Scale (PCS)) is about the same for the older and younger groups, based on non-age-refer-
enced general US population norms. Since age effects on cognition are somewhat controlled 
for by the age-referenced norms, these cross-sectional results appear to indicate some degree 
of decrease in cognitive performance, but not mood or physical functioning, for the older 
group within this pilot sample of individuals with cerebral small vessel disease.
  For the 10 participants over the age of 65, standard scores were calculated for the RBANS 
index scores using both the age-referenced manual norms and the age- and education-refer-
enced norms from Duff et al.   [11]  . While the RBANS total scale scores were similar using 
both norms, the RBANS individual index scores varied according to which norms were used. 
Attention, immediate memory, and delayed memory index scores were higher using the 
norms from Duff et al.   [11]  , while language and visuospatial/construction were lower.
   Table 3  presents scores for a subsample of 9 participants with available data for two time 
points using the computer-based cognitive measure, and the mood and daily functioning 
measures. For this subsample, the cognitive scores show a very slight and statistically non-
significant decline over time, while the physical functioning and mood scores show a slight 
improvement.
      Table 4   presents a summary of the clinical report findings for structural and functional 
imaging and the neuropsychology test result findings for the 14 participants. The presence 
and extent of small vessel disease is noted for each participant’s available structural and func-
tional imaging. It is important to note that although we used strict inclusion and exclusion 
criteria for cerebral small vessel disease, 9 of the 14 participants had questions of other disease 
processes raised in the clinical reports of functional and/or structural imaging. Of the 13 par-
ticipants with neuropsychology test domains that are below one standard deviation from the 
normative mean score, 10 participants’ scores include at least one domain that would be ex-
pected to be affected by cerebral small vessel disease (i.e. attention, speed, executive function, 
and memory retrieval).
    A case study illustrates differences in structural and functional imaging findings with 
mild neuropsychology findings (please refer to Case 3 inside   table 4  ). For this 84-year-old 
White woman, the neuropsychology test results, presented in   figure 1  , show some mild de-
creased performance on measures of executive function (CLOX1, FAS, TMT B), speed (TMT 
A), working memory (WAIS Digit span), and on the attention index score of the RBANS. No 
depression (GDS) or decreased daily functioning (PCS, MCS) was reported, beyond diffi-
culty with managing a large house. While the decreases in cognitive performance are mild, 
they include areas typically affected by cerebral small vessel disease.
    The MRI report for this case study described no significant intracranial abnormality, 
and no abnormality of perfusion. Nonetheless, the SPECT imaging report noted a mild to 
moderate multifocal pattern of hypoperfusion in the white matter, patchy hypoperfusion in 
the left lenticular nucleus, and regional hypoperfusion in the anterior temporal cortices 
(trace to mild) with some generalized increased heterogeneity of cortical perfusion bihemi-
spherically, all consistent with small vessel disease. No pattern of hypoperfusion on SPECT 
was seen that would be suggestive of large vessel disease, neurodegenerative disease, or psy-
chiatric disorder. This case illustrates the potential usefulness of functional imaging in iden-
tifying changes in perfusion in the absence of structural abnormalities identified on MRI.176
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  Discussion
    This article presents results from a small pilot sample selected using specific inclusion/
exclusion criteria for cerebral small vessel disease from a follow-up neurology stroke clinic. 
These pilot results illustrate some neuropsychological characteristics and imaging findings 
associated with this disease process. Scores among the older subsample were somewhat low-
er compared to the younger sample, generally for measures of attention, speed of processing, 
and memory and executive functioning. In contrast, mood was better among the older group. 
Performance on a computer-based cognitive measure was generally stable over a short time 
interval, with a very slight overall decline, which was not significant. Physical functioning 
showed improvement, possibly associated with recovery from a clinically evident lacunar 
stroke.
    Most participants in this pilot sample demonstrated performance below one standard 
deviation from the normative mean score in the domains commonly affected by cerebral 
small vessel disease (i.e. attention, speed, executive functioning, and memory retrieval). For 
most participants, clinical report findings on SPECT imaging were consistent with cerebral 
small vessel disease. Mention of small vessel disease in clinical reports for MRI, or notation 
of white matter hyperintensities or lacunes was mixed for the participants. On structural and 
functional imaging for the case example with mild neuropsychology findings, the clinical 
report from structural MRI was normal, while the SPECT report of functional imaging iden-
tified perfusion abnormalities.
    These preliminary findings are generally consistent with previous studies involving 
structural and functional imaging. In the prospective Leukoaraiosis and Disability Study  [6] , 
white matter hyperintensities and lacunes on MRI were independently associated with gen-
eral cognitive function in a prospective sample of 639 participants aged 65–84 years. This 
prospective sample had no or only mild disability in their instrumental activities of daily liv-
ing. Van Dijk et al.   [22]   used a semiquantitative scale to rate incident lacunar infarcts and 
change in periventricular and subcortical white matter lesion severity over a three-year pe-
  Fi g .  1.   Cognition, mood, and daily functioning at baseline for an 84-year-old female with 14 years of edu-
cation. 177
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riod among 685 persons 60 to 90 years of age. Lesion progression was associated with a par-
allel decrease in speed of information processing and general cognitive function.
    Using SPECT imaging, Kato et al.   [23]   studied localized regional blood flow changes 
among 15 participants with early-stage dementia from cerebral small vessel disease. They 
found hypoperfusion in the pulvinar nucleus of the thalamus compared to controls, and in 
the left pulvinar thalamic nucleus compared to participants with white matter lesions but 
without dementia. Shim et al.  [24]  used SPECT imaging to compare two subtypes of cerebral 
small vessel disease, Binswanger’s disease and the lacunar state. Among 25 participants with 
cerebral small vessel disease, they found cerebral blood flow reductions in several regions, 
including the thalamus bilaterally, the anterior cingulated gyri, the superior temporal gyri, 
the caudate heads, and the left parahippocampal gyrus. The Binswanger’s disease suptype 
did not differ from the lacunar state subtype of cerebral small vessel disease in the pattern 
of regional cerebral blood flow.
  Recent developments in neuroimaging analysis, such as the Easy Z-Score Imaging Anal-
ysis System (eZIS), will allow for future research into computer analysis of SPECT images as 
an adjunct to early diagnosis   [25, 26]  . The eZIS analysis allows comparison of an individual 
SPECT image, or a composite group of images, to a normal database of SPECT images that 
is adjusted for the specific SPECT camera used to obtain the patient image   [27–30]  . Specific 
regions of interest can be examined for hypoperfusion, and perfusion in regions of interest 
can be associated with neuropsychological test scores through the use of statistical paramet-
ric mapping   [23, 31]  .
    This descriptive report of preliminary data has a number of limitations. The sample is a 
small pilot sample without a control group, and so caution is needed in generalizing the re-
sults. The comparison between younger and older age groups is only descriptive and should 
be interpreted as such. The MRI and SPECT data was not reviewed in a blinded fashion and 
was not scored in a prospective, quantitative manner. A prospective and blind to cognitive 
status reading using standardized a priori criteria can be used in future studies. Recruitment 
occurred over an extended time period, as the study was a lower priority than other research 
studies being conducted at the stroke center, and numerous patients were screened and found 
ineligible. The sample was collected using strict criteria for cerebral small vessel disease, 
nonetheless participants had questions of other disease processes raised in the clinical re-
ports of functional and/or structural imaging. One of the participants did not meet criteria 
for dementia at enrollment, yet performed near or below two standard deviations from the 
mean on tests of speed, immediate and delayed memory, and verbal fluency. Daily function-
ing was also in this range. MRI findings were consistent with the cerebral amyloid angiopa-
thy type of small vessel disease. This participant was excluded from the study after the initial 
assessment. 
  These results do raise a number of questions for further research. One question involves 
the potential of functional imaging such as SPECT or fMRI, combined with advances in im-
aging analysis, to identify the cerebral small vessel disease process even before changes are 
noticed in cognition. Another question involves whether structural MRI can identify cere-
bral small vessel disease as well as functional imaging. Cerebral small vessel disease often 
occurs along with another disease process, such as Alzheimer’s disease. Future research can 
address the differential diagnosis of cerebral small vessel disease as a distinct entity, as well 
as its role in interaction with other disease entities affecting decline in cognition, mood, and 
daily functioning.178
Dement Geriatr Cogn Disord Extra 2012;2:169–179
 DOI:  10.1159/000333482 
  Published online: April 18, 2012 
EXTRA
  Baker et al.: Cerebral Small Vessel Disease 
www.karger.com/dee
    © 2012 S. Karger AG, Basel
 References 
    1  Loeb C, Meyer JS: Vascular dementia: still a debatable entity? J Neurol Sci 1996;    143:    31–40.
      2  Pantoni L: Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeu-
tic challenges. Lancet Neurol 2003;9:689–701.
      3  Chui H: Dementia due to subcortical ischemic vascular disease. Clin Cornerstone 2001;    3:    40–51.
    4  Meyer JS, Xu G, Thornby J, Chowdhury MH, Quach M: Is mild cognitive impairment prodromal for 
vascular dementia like Alzheimer’s disease? Stroke 2002;    33:    1981–1985.
     5  Grau-Olivares M, Arboix A: Mild cognitive impairment in stroke patients with ischemic cerebral 
small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurotherap 2009;    9:    1201–1217.
      6  Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, Scheltens P, Barkhof 
F, Visser MC, Fazekas F, Schmidt R, O’Brien J, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzi-
tari D, Erkinjuntti T: Longitudinal cognitive decline in subcortical ischemic vascular disease–the 
LADIS Study. Cerebrovasc Dis 2009;    27:    384–391.
      7  Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC: Executive dysfunction in subcortical isch-
aemic vascular disease. J Neurol Neurosurg Psychiatry 2002;    72:    217–220.
      8  Lesage SR, Mosley TH, Wong TY, Szklo M, Knopman D, Catellier DJ, Cole SR, Klein R, Coresh J, 
Coker LH, Sharrett AR: Retinal microvascular abnormalities and cognitive decline: the ARIC 14-
year follow-up study. Neurology 2009;    73:    862–868.
      9  Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MMB: 
Cerebral small-vessel disease and decline in information processing speed, executive function and 
memory. Brain 2005;    128:    2034–2041.
    10  Zhou A, Jia J: Different cognitive profiles between mild cognitive impairment due to cerebral small 
vessel disease and mild cognitive impairment of Alzheimer’s disease origin. J Int Neuropsychol Soc 
2009;    15:    898–905.
    11  Duff K, Patton D, Schoenberg MR, Mold J, Scott JG, Adams RL: Age- and education-corrected inde-
pendent normative data for the RBANS in a community dwelling elderly sample. Clin Neuropsychol 
2003;    17:    351–366.
    12  Duff K, Schoenberg MR, Patton D, Paulsen JS, Bayless JD, Mold J, Scott JG, Adams RL: Regression-
based formulas for predicting change in RBANS subtests with older adults. Arch Clin Neuropsychol 
2005;    20:    281–290.
    13  Darby D, Maruff P, Collie A, McStephen M: Mild cognitive impairment can be detected by multiple 
assessments in a single day. Neurology 2002;    59:    1042–1046.
    14  Maruff P, Thomas E, Cysique L, Brew B, Collie A, Snyder P, Pietrzak RH: Validity of the CogState 
brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild trau-
matic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol 2009;    24:   
 165–178.
    15  Sabri O, Hellwig D, Schreckenberger M, Cremerius U, Schneider R, Kaiser HJ, Doherty C, Mull M, 
Ringelstein EB, Buell U: Correlation of neuropsychological, morphological and functional (regional 
cerebral blood flow and glucose utilization) findings in cerebral microangiopathy. J Nucl Med 1998;   
 39:    147–154.
    16  Yoshikawa T, Murase K, Oku N, Kitagawa K, Imaizumi M, Takasawa M, Nishikawa T, Matsumoto 
M, Hatazawa J, Hori M: Statistical image analysis of cerebral blood flow in vascular dementia with 
small-vessel disease. J Nucl Med 2003;    44:    505–511.
  Acknowledgements
    Funding for this study was provided by a grant from the Gustavus and Louise Pfeiffer 
Research Foundation.
  We would like to acknowledge the contributions of Kathy Parkes and Cheryl Conover of 
the Neurology Department of the University at Buffalo and Millard Fillmore Gates Circle 
Hospital in recruiting patients and coordinating and managing the data collection. We 
would also like to acknowledge the contributions of the participants to the study. 179
Dement Geriatr Cogn Disord Extra 2012;2:169–179
 DOI:  10.1159/000333482 
  Published online: April 18, 2012 
EXTRA
  Baker et al.: Cerebral Small Vessel Disease 
www.karger.com/dee
  © 2012 S. Karger AG, Basel 
    17  Grau-Olivares M, Arboix A, Bartres-Faz D, Junque C: Neuropsychological abnormalities associated 
with lacunar infarction. J Neurol Sci 2007;    257:    160–165.
    18  O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCar-
li C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. 
Lancet Neurol 2003;    2:    89–98.
    19  Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC: Subcortical ischaemic vascular dementia. 
Lancet Neurol 2002;    1:    426–436.
    20  Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Des-
mond DW: Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 
2000;59:23–30.
    21  Lezak MD, Howieson DB, Loring DW: Neuropsychological assessment. New York, Oxford Univer-
sity Press, 2004.
  22  van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM: Progression of cerebral 
small vessel disease in relation to risk factors and cognitive consequences. Stroke 2008;    39:    2712–2719.
    23  Kato H, Yoshikawa T, Oku N, Imaizumi M, Takasawa M, Kimura Y, Kajimoto K, Tanaka M, Kitaga-
wa K, Hori M, Hatazawa J: Statistical parametric analysis of cerebral blood flow in vascular demen-
tia with small-vessl disease using Tc-HMPAO SPECT. Cerebrovasc Dis 2008;    26:    556–562.
    24  Shim YS, Yang DW, Kim BS, Shon YM, Chung YA: Comparison of regional cerebral blood flow in 
two subsets of subcortical ischemic vascular dementia: statistical parametric mapping analysis of 
SPECT. J Neurol Sci 2006;    250:    85–91.
    25  Waragai M, Mizumura S, Yamada T, Matsuda H: Differentiation of early-stage Alzheimer’s disease 
from other types of dementia using brain perfusion single photon emission computed tomography 
with easy Z-score imagine system analysis. Dement Geriatr Cogn Disord 2008;    26:    547–555.
  26  Waragai M, Yamada T, Matsuda H: Evaluation of brain perfusion SPECT using an easy Z-score (eZIS) 
as an adjuct to early-diagnosis of neurodegenerative diseases. J Neurol Sci 2007;    260:    57–64.
    27  Matsuda H, Mizumura S, Soma T, Takemura N: Conversion of brain SPECT images between differ-
ent collimators and reconstruction processes for analysis using statistical parametric mapping. Nucl 
Med Commun 2004;    25:    67–74.
    28  Mizumura S, Kumita S: Stereotactic statistical imaging analysis of the brain using the easy Z-score 
imaging system for sharing a normal database. Radiat Med 2006;    24:    545–552.
  29  Matsuda H, Mizumura S, Nagao T, Ota T, Iizuka T, Nemoto K, Kimura M, Tateno A, Ishiwata A, Kuji 
I, Arai H, Homma A: An easy Z-score imaging system for discrimination between early Alzheimer’s 
disease and controls using brain perfusion SPECT in a multicentre study. Nucl Med Commun 2007;   
 28:    199–205.
  30  Matsuda H, Mizumura S, Nagao T, Ota T, Iizuka T, Nemoto K, Takemura N, Arai H, Homma A: Au-
tomated discrimination between very early Alzheimer disease and controls using an easy Z-score 
imaging system for multicenter brain perfusion single-photon emission tomography. AJNR Am J 
Neuroradiol 2007;    28:    731–736.
    31  Ikeda E, Shiozaki K, Takahashi N, Togo T, Odawara T, Oka T, Inoue T, Hirayasu Y: Total Mini-Men-
tal State Examination score and regional cerebral blood flow using Z score imaging and automated 
ROI analysis software in subjects with memory impairment. Ann Nucl Med 2008;    22:    539–542. 